Who said this proposed consolidation was due to commercialisation when we all know Azer-Cel is a few years???? The short term catalysts are the clinical trial updates from VAXINIA and OASIS so are planning for the CR and the participant don't want a high O/S as we know IMU will need to do one either next quarter if the $26M warrant isn't exercised and they continue to spend $20M on R&D like last quarter or at the end of the year like PH stated if they don't with the next few quarter expenditure $12-15M.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)